For instance, Kim et al. observed that SRC kinase signaling induced EMT in residual breast cancer cells after irradiation, thus increasing CSC signatures related to the CD44+/CD24- phenotype, chemoresistance, invasiveness, and migration [55,56], suggesting the importance of SRC kinase in therapy resistance. This evidence concerns the gene CD44 and breast carcinoma.